List view / Grid view
14 March 2024 | By Drug Target Review
Join us for this webinar as we explore the role of organoids in advancing treatment of neurological disorders. Organoids, miniature 3D models of human organs, are at the forefront of neuroscience research, offering insights into the complexities of the human brain. In this webinar, esteemed experts will explore the latest…
The potential for brain organoids to develop consciousness is a key issue in neuroscience, which has prompted new ethical considerations.
Dr Amber Van Laar shares her remarkable journey in STEM. From a childhood fascination with science and medicine to a pivotal role as VP Clinical Development, AskBio. In this interview, she explores the profound impact of her early exposure to neuro-oncology, the challenges faced as a physician-scientist, and the pursuit…
Future interventions for ischaemic stroke patients should enhance collateral function to reduce brain haemorrhage and mortality.
Researchers discovered that NPTX2 protein accumulated in cells containing abnormal TDP-43 in FTD and ALS patients.
Researchers have uncovered the role of the PL-BLA neuronal axis and its potential function in DOP-mediated anxiolytic effects.
Researchers have found that using protein-like polymers to inhibit the Keap1/Nrf2 PPI is a powerful therapeutic strategy.
For the first time, researchers reveal the involvement of OXT in object recognition memory through the supramammillary nucleus.
A mechanism by which the immune system influences central nervous system function and behaviour has been discovered.
Explore an MEA workflow used to validate the ALS-relevant phenotype of precision reprogrammed iPSC-derived neuronal disease models of ALS from bit.bio
In the world of neuroscience, where the unmet medical need is vast and diverse, the journey to develop and commercialise treatments for neurological diseases, including rare conditions, is fraught with challenges. In this insightful interview with Dr Bruce Leuchter, President and CEO at Neurvati Neurosciences, with over two decades of…
A new project plans to elucidate the relationship between the glucosylceramidase beta gene and Parkinson’s disease.
A new learning-based framework enables patients and caregivers to predict the timing of any of the five clinical groups of AD development.
Listen to this podcast where we step into the new year and explore research insights and projections for the field in 2024 in neuroscience.
Low dose ionising radiation reduced lesion size and reversed motor deficits in traumatic brain injury and ischemic stroke mice.
